Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 18, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Responsive neurostimulation (RNS) programming.

Philip M McCarthy1, David E Burdette1

  • 1Corewell Health Medical System Department of Neurosciences, USA; Michigan State University College of Human Medicine, USA.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|June 16, 2026
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months.

Epilepsia·2026
Same author

Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results.

Neurology·2026
Same author

Centromedian nucleus targeting in the pediatric population treated with thalamic responsive neurostimulation for drug-resistant epilepsy.

Epilepsia open·2025
Same author

Thalamic highways as a bridge to neuromodulation.

Brain : a journal of neurology·2025
Same author

Synergistic seizure reduction in patient with persistently elevated N-desmethylclobazam levels, CYP450 genetic polymorphism, and responsive neurostimulator targeting centromedian nuclei of bilateral thalami.

Epilepsy & behavior reports·2025
Same author

Bilateral pulvinar responsive neurostimulation for bilateral multifocal posteriorly dominant drug resistant epilepsy.

Epilepsia open·2024
Same journal

Nervonic acid and the long arc of therapeutic hope in X-linked adrenoleukodystrophy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Long-term efficacy of subthalamic nucleus deep brain stimulation in focal motor seizures and implications for candidate selection.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Brain interstitial fluid pharmacokinetics and therapeutic effect of a BBB penetrating amyloid beta antibody measured by microdialysis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Advances in the management of pediatric low-grade glioma.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Therapeutic hypothermia protects the ischemic penumbra via Xkr8.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Long-term safety and efficacy of deoxycytidine/deoxythymidine in treatment of POLG-related disorders.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
See all related articles

Responsive neurostimulation (RNS) programming uses electrocorticographic biomarkers to guide stimulation parameter adjustments. This approach aims to reduce seizure frequency and severity through optimized neurostimulation timing and paradigms.

Area of Science:

  • Neurology
  • Neuroscience
  • Biomedical Engineering

Background:

  • Responsive neurostimulation (RNS) is an adaptive neuromodulation therapy for epilepsy.
  • Programming RNS involves optimizing stimulation parameters based on detected brain activity.

Purpose of the Study:

  • To detail the process of identifying and detecting electrocorticographic biomarkers for RNS programming.
  • To present a practical framework for advancing stimulation paradigms to maximize seizure control.

Main Methods:

  • Review of general principles for different neurostimulation paradigms.
  • Identification and detection of specific seizure phase biomarkers (pro-ictal, pre-ictal, ictal onset, seizure body).
  • Stepwise progression of stimulation parameters informed by biomarker detection.
Keywords:
EpilepsyRNS targetsResponsive neurostimulation (RNS)Seizure biomarkersSeizure detection

More Related Videos

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
13:18

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Related Experiment Videos

Last Updated: Jun 18, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
13:18

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Main Results:

  • Established a logical progression for RNS programming based on biomarker detection.
  • Demonstrated how biomarker detection informs optimal neurostimulation timing.
  • Presented a practical approach to RNS programming for improved seizure management.

Conclusions:

  • RNS programming is an iterative, biomarker-driven process.
  • Optimized neurostimulation timing and paradigms enhance acute seizure disruption and long-term neuromodulation.
  • This approach aims for sustained improvements in seizure frequency and severity.